- Home
- ABEO vs ASLE Comparison
ABEO vs ASLE Comparison
Compare ABEO & ASLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- ASLE
- Stock Information
- Founded
- ABEO 1974
- ASLE 2008
- Country
- ABEO United States
- ASLE United States
- Employees
- ABEO N/A
- ASLE N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- ASLE Industrial Specialties
- Sector
- ABEO Health Care
- ASLE Consumer Discretionary
- Exchange
- ABEO Nasdaq
- ASLE Nasdaq
- Market Cap
- ABEO 256.9M
- ASLE 276.5M
- IPO Year
- ABEO 1980
- ASLE N/A
- Fundamental
- Price
- ABEO $5.57
- ASLE $6.01
- Analyst Decision
- ABEO Strong Buy
- ASLE Strong Buy
- Analyst Count
- ABEO 6
- ASLE 3
- Target Price
- ABEO $18.00
- ASLE $8.67
- AVG Volume (30 Days)
- ABEO 1.1M
- ASLE 292.2K
- Earning Date
- ABEO 08-11-2025
- ASLE 08-06-2025
- Dividend Yield
- ABEO N/A
- ASLE N/A
- EPS Growth
- ABEO N/A
- ASLE N/A
- EPS
- ABEO N/A
- ASLE N/A
- Revenue
- ABEO N/A
- ASLE $320,302,000.00
- Revenue This Year
- ABEO N/A
- ASLE $2.54
- Revenue Next Year
- ABEO $323.51
- ASLE $16.24
- P/E Ratio
- ABEO N/A
- ASLE N/A
- Revenue Growth
- ABEO N/A
- ASLE N/A
- 52 Week Low
- ABEO $3.93
- ASLE $4.53
- 52 Week High
- ABEO $7.32
- ASLE $8.76
- Technical
- Relative Strength Index (RSI)
- ABEO 37.51
- ASLE 49.24
- Support Level
- ABEO $5.66
- ASLE $5.66
- Resistance Level
- ABEO $6.24
- ASLE $6.12
- Average True Range (ATR)
- ABEO 0.26
- ASLE 0.18
- MACD
- ABEO -0.08
- ASLE 0.04
- Stochastic Oscillator
- ABEO 8.08
- ASLE 76.92
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About ASLE AerSale Corporation
AerSale Corp is an integrated, diversified leader in aviation aftermarket products and services. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing a broad range of maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. The company operating segment includes Asset Management Solutions and TechOps. It generates maximum revenue from the Asset Management Solutions segment.